Spectrum Pops 71% In After-Hours On ‘Positive’ Data For Lung Cancer Treatment

Shares in Spectrum Pharmaceuticals (SPPI) jumped 71% in extended trading after announcing positive topline results from a Phase 2 clinical trial evaluating its …

Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks

Penny stocks give a whole new meaning to risk/reward plays. These tickers can witness explosive movements in the blink of an eye, giving …

Spectrum Pharmaceuticals’ (SPPI) Encouraging Clinical Update in NSCLC Gets the Bulls in a Buying Frenzy

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) just riled up Wall Street today with enticing Phase 2 study results in non-small cell lung cancer (NSCLC), sending …

Spectrum Pharmaceuticals, Inc. (SPPI) More Than Doubles Its Positive Responses Goal with Slam Dunk Updated Phase II Trial; H.C. Wainwright Chimes In

Edward White sees positive road ahead after SPPI’s compelling cancer asset hits ORR of 73% in Exon 20.

Investors Race to Buy Spectrum Pharmaceuticals, Inc. (SPPI) Shares; Here’s Why

Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 50% upturn.

H.C. Wainwright Remains Positive on Spectrum Pharmaceuticals, Inc. (SPPI) Despite FDA AdCom Setback

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is dealing with the rejection from yesterday’s FDA Oncology Advisory Committee meeting for its pipeline drug Qapzola (apaziquone), designed …

Biotech Beat: Analysts Weigh In On Valeant Pharmaceuticals Intl Inc (VRX), Synergy Pharmaceuticals Inc (SGYP), Spectrum Pharmaceuticals, Inc. (SPPI)

Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX), NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and NV-based pharma company …

H.C. Wainwright Remains Positive On Spectrum Pharmaceuticals Following Unfavorable Patent Ruling

In a research report released Monday, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts